Efficacy and Safety of Ulotaront in the Treatment of Schizophrenia: Results of Two 6-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials

被引：0
|
作者：
Kane, John [1 ]
Dworak, Heather [1 ]
Koblan, Kenneth [1 ]
Szegedi, Armin [1 ]
Goldman, Robert [1 ]
Li, Yan [1 ]
Fitzgerald, Alison [1 ]
Loebel, Antony [1 ]
Marder, Stephen [1 ]
机构：
[1] Sunovion Pharmaceut Inc, Teaneck, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷
关键词：
Schizophrenia (SCZ); TAAR1; Phase III Trial; Clinical Trial; Ulotaront;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P495
引用
收藏
页码：351 / 351
页数：1
相关论文
共 50 条
  • [41] THE EFFICACY OF ZILEUTON IN THE TREATMENT OF ASTHMA - RESULTS OF COMBINED DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS
    DRAZEN, J
    ISRAEL, E
    COHN, J
    DUBE, L
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 388 - 388
  • [42] Efficacy and Safety of Yokukansan in Treatment-Resistant Schizophrenia: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
    Miyaoka, Tsuyoshi
    Furuya, Motohide
    Horiguchi, Jun
    Wake, Rei
    Hashioka, Sadayuki
    Thoyama, Masaya
    Murotani, Kenta
    Mori, Norio
    Minabe, Yoshio
    Iyo, Masaomi
    Ueno, Shuichi
    Ezoe, Sachiko
    Hoshino, Syuzo
    Seno, Haruo
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [43] A randomized, double-blind, placebo-controlled efficacy and safety study of bifeprunox as treatment for patients with acutely exacerbated schizophrenia
    Meltzer, H.
    Barbato, L. M.
    Heisterberg, J.
    Yeung, P. P.
    Shapira, N. A.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 446 - 446
  • [44] A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults
    He, Shen
    Yu, Yimin
    Huang, Jingjing
    Yin, Jiahui
    Niu, Yajuan
    Lu, Yazhou
    Wu, Bin
    Fang, Maosheng
    Wang, Xue
    Tao, Zhiping
    Li, Lehua
    Li, Kan
    Li, Yan
    Ding, Xiujuan
    Shen, Yifeng
    Li, Huafang
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2023, 13
  • [45] Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Allen, Michael H.
    Feifel, David
    Lesem, Michael D.
    Zimbroff, Daniel L.
    Ross, Ruth
    Munzar, Patrik
    Spyker, Daniel A.
    Cassella, James V.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (10) : 1313 - 1321
  • [46] Efficacy and safety of brexpiprazole in schizophrenia: Meta-analysis of three double-blind, randomized, placebo-controlled phase 3 studies
    Weiss, C.
    Zhang, P.
    Hakala, M. J.
    Skuban, A.
    Weiller, E.
    EUROPEAN PSYCHIATRY, 2016, 33 : S109 - S109
  • [47] Efficacy and Tolerability of Lurasidone in Older Adults with Bipolar Depression: Analysis of Two 6-week Double-blind, Placebo-controlled Studies
    Sajatovic, M.
    Forester, B.
    Tsai, J.
    Kroger, H.
    Pikalov, A.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [48] A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL, DOUBLE-BLIND, 6-WEEK MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PARTICIPANTS WITH OBSTRUCTIVE SLEEP APNEA
    Strollo, P. J.
    Redline, S.
    Hedner, H.
    Collop, N.
    Lorch, D. G., Jr.
    Chen, D.
    Li, J.
    Carter, L. P.
    Lu, Y.
    Black, J.
    Pepin, J. L.
    SLEEP, 2017, 40 : A238 - A238
  • [49] Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
    Masaaki Ogasa
    Tatsuya Kimura
    Mitsutaka Nakamura
    John Guarino
    Psychopharmacology, 2013, 225 : 519 - 530
  • [50] OMALIZUMAB EFFICACY AND SAFETY IN NASAL POLYPOSIS: RESULTS FROM TWO PARALLEL, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS
    Gevaert, P.
    Bachert, C.
    Corren, J.
    Mullol, J.
    Han, J.
    Ow, R.
    Islam, L.
    Howard, M.
    Owen, R.
    Wong, K.
    Kaufman, D.
    Omachi, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S17 - S17
12345